# 3.3.1.3 Cases with Grade 3 Infections

**Page range:** 52–52

```text
3.3.1.3
Cases with Grade 3 Infections
A total of 276 cases reporting 311 Grade 3 AEs infections (along with 2 Grade 5 AEs
and 8 Grade 4 AEs16) were retrieved from Company Safety Database.
An overview of characteristics of these cases reporting Grade 3 AEs is presented in
Table 17.
Table 17 Summary of Characteristics of Cases Involving the Use of
Pralsetinib and Reporting Grade 3 Infections from the Safety
Database (N=276)
Characteristic
Number of Cases (%)
Primary Reporter Type
Healthcare Professional
214 (77.5)
Non-Healthcare
Professional/Consumer
62 (22.5)
Sex
Male
131 (47.5)
Female
143 (51.8)
Not reported
2 (0.7)
Age (Years)
Range: 34 to 87
Mean: 65.6
Median: 65
18 to 64 (Adult)
149 (54.0)
65 (Elderly)
126 (45.7)
Not reported
1 (0.4)
Source
Clinical Study
258 (93.5)
Non-Interventional
Study/Program
16 (5.8)
Spontaneous
2 (0.7)
Indication groups
Lung Cancer
141 (51.1)
Thyroid Cancer
111 (40.2)
Other malignancies
20 (7.2)
Not reported
4 (1.4)
MeDRA version: 27.0

```